TetraLogic Pharmaceuticals CorporationCompany Review & Valuation

TLOG
OTC Markets
Latest Price
0.02USD
Market Capitalization
489.30kUSD

About TetraLogic Pharmaceuticals Corporation

TetraLogic Pharmaceuticals Corporation, a clinical-stage biopharmaceutical company, focuses on discovering and developing small molecule therapeutics in oncology and infectious diseases. It has two clinical-stage product candidates in development, such as birinapant and SHAPE. Birinapant is a small Show moremolecule therapeutic that mimics Second Mitochondrial Activator of Caspases-mimetic, which leads to apoptosis or cell-death in damaged cells. SHAPE is its proprietary histone deacetylase inhibitor for topical use for the treatment of early-stage cutaneous T-cell lymphoma. TetraLogic Pharmaceuticals Corporation has research collaboration with Walter and Eliza Hall Institute of Medical Research to examine SMAC-mimetics, including birinapant in the treatment of infectious disease. The company was formerly known as Gentara Corporation and changed its name to TetraLogic Pharmaceuticals Corporation in January 2006. TetraLogic Pharmaceuticals Corporation was incorporated in 2001 and is headquartered in Malvern, Pennsylvania.Show less

Industry
Biotechnology
HQ Location
Malvern, Pennsylvania

Stock Price

Price data not available for TetraLogic Pharmaceuticals Corporation.

Performance

Please login or create a free account to view the contents of this section.

Similar Companies

Alexion Pharmaceuticals
Acorda Therapeutics
Kalytera Therapeutics
BioCryst Pharmaceuticals

back to top